Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Taysha Gene Therapies to Release Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 12
-
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
-
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study
-
Viasat Releases First Quarter Fiscal Year 2026 Financial Results
-
Sow Good Appoints Candy Industry Veteran Jeff Rubin to Board of Directors
-
Noodles & Company Names Joseph D. Christina as President and CEO
-
OraSure Announces Second Quarter 2025 Financial Results
-
Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2025 Guidance
-
OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
-
Weyco Reports Second Quarter Sales and Earnings
-
Astera Labs Announces Financial Results for the Second Quarter of Fiscal Year 2025
-
Methode Electronics to Present at the J.P. Morgan Auto Conference
-
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights
-
LifeMD Reports Second Quarter 2025 Results
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
Appian To Participate in Upcoming Investor Conferences
-
AvePoint to Participate in Upcoming Investor Conferences
-
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
-
Datadog to Present at Upcoming Investor Conferences
-
Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
-
Spero Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on Tuesday, August 12, 2025
-
Ceribell Reports Second Quarter 2025 Financial Results
-
Amwell® Announces Results for Second Quarter 2025
-
Paylocity Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results
-
-
Carlyle Secured Lending, Inc. Announces Financial Results For Second Quarter Ended June 30, 2025, Declares Third Quarter 2025 Dividend of $0.40 Per Common Share
-
Clearway Energy, Inc. Reports Second Quarter 2025 Financial Results
-
Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update
-
Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure
-
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results
-
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
-
ScanTech AI Announces DeMeakey Williams, Sr. as Senior Vice President of Sales, Business Development, and Investor Relations
-
Latham Group, Inc. Reports Second Quarter 2025 Financial Results
-
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
SLR Investment Corp. Announces Quarter Ended June 30, 2025 Financial Results
-
United Fire Group, Inc. reports second quarter 2025 results
-
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
-
BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
-
OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Premium Income Corporation Announces Monthly Distribution
-
IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call
-
Pacira BioSciences Reports Second Quarter 2025 Financial Results
-
Comscore Reports Second Quarter 2025 Results
-
Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
